BACE1 and Alzheimer disease: Here, we identify ramalin, a natural antioxidant, as a promising therapeutic agent that alleviates AD pathology by modulating β‐site APP cleaving enzyme 1 (BACE1), histone deacetylase 6 (HDAC6), and the mitogen‐activated protein kinases (MAPK) pathway.